Medtronic tests graft use in smaller AAAs (abdominal aortic aneurysms):
This article was originally published in Clinica
Executive Summary
Medtronic is tackling the debate over the value of endovascular grafting in patients with small abdominal aortic aneurysms (AAAs). It has begun a US trial to assess whether treating certain aneurysms smaller than 5cm in diameter with a graft is superior to periodic surveillance, or "watchful waiting". The prospective, randomised study, which will use the firm's AneuRx AAA stent graft in patients undergoing endovascular intervention, will enrol nearly 1,700 subjects at over 50 centres. Its primary endpoint is the cumulative occurrence of the composite of rupture or aneurysm-related death within three years. The trial's results could alter thinking surrounding the use of endovascular stent graft systems, said Medtronic.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.